Impact of medication nonadherence on coronary heart disease outcomes - A critical review

被引：154

作者：

McDermott, MM

Schmitt, B

Wallner, E

机构：

[1] NORTHWESTERN UNIV, SCH MED, DIV GEN INTERNAL MED, CHICAGO, IL USA

[2] VET AFFAIRS CHICAGO HLTH CARE SYST, LAKESIDE DIV, CHICAGO, IL USA

来源：

ARCHIVES OF INTERNAL MEDICINE | 1997年 / 157卷 / 17期

关键词：

D O I：

10.1001/archinte.157.17.1921

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A critical review of published literature was performed to assess the impact of medication adherence on morbidity and mortality among patients with or at risk for coronary artery disease and congestive heart failure. Twenty-one original research articles that met our inclusion criteria and related medication adherence to morbidity and mortality are summarized. No clinical trials that specifically tested the impact of a compliance-enhancing intervention on outcome in coronary heart disease were identified. Among 12 studies that compared hospitalization rates and mortality between adherers and nonadherers, 7 showed a significant relationship between medication adherence and outcomes. Three studies showed that adherence to placebo was associated with improved outcomes, suggesting that adherent behavior may be a marker of better prognosis or confers a protective effect on patients with coronary heart disease. Further study is necessary to determine whether adherent behavior can be taught and whether compliance-enhancing strategies improve outcomes in coronary heart disease.

引用

页码：1921 / 1929

页数：9

共 34 条

[1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[2]

CANNER PL, 1980, NEW ENGL J MED, V303, P1038

[3] ADVERSE DRUG-REACTIONS AND DRUG NON-COMPLIANCE AS PRIMARY CAUSES OF ADMISSION TO A CARDIOLOGY DEPARTMENT [J].

DAVIDSEN, F ;

HAGHFELT, T ;

GRAM, LF ;

BROSEN, K .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 34 (01) :83-86

[4] THE EFFECT OF MEDICATION COMPLIANCE ON THE CONTROL OF HYPERTENSION [J].

EISEN, SA ;

WOODWARD, RS ;

MILLER, D ;

SPITZNAGEL, E ;

WINDHAM, CA .

JOURNAL OF GENERAL INTERNAL MEDICINE, 1987, 2 (05) :298-305

[5]

FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707

[6] THE RELATIONSHIP OF TREATMENT ADHERENCE TO THE RISK OF DEATH AFTER MYOCARDIAL-INFARCTION IN WOMEN [J].

GALLAGHER, EJ ;

VISCOLI, CM ;

HORWITZ, RI .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (06) :742-744

[7] PRECIPITATING FACTORS LEADING TO DECOMPENSATION OF HEART-FAILURE - TRAITS AMONG URBAN BLACKS [J].

GHALI, JK ;

KADAKIA, S ;

COOPER, R ;

FERLINZ, J .

ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (09) :2013-2016

[8] PROGNOSTIC FACTORS IN ACUTE PULMONARY-EDEMA [J].

GOLDBERGER, JJ ;

PELED, HB ;

STROH, JA ;

COHEN, MN ;

FRISHMAN, WH .

ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (03) :489-493

[9]

GOODMAN L, 1994, MED KNOWLEDGE SELF A, V417

[10] FINAL REPORT ON THE ASPIRIN COMPONENT OF THE ONGOING PHYSICIANS HEALTH STUDY [J].

HENNEKENS, CH .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) :129-135

← 1 2 3 4 →